UNSPSC 51343205: Elvitegravir

A type of human immunodeficiency virus type 1 (HIV-1) integrasestrand transfer inhibitor used in combination with an HIV proteaseinhibitor coadministered with ritonavir and with other antiretroviraldrug(s) indicated for the treatment of HIV-1 infection in antiretroviraltreatment-experienced adults.

UNSPSC 51343205 Elvitegravir is a Commodity code that, based on recent state and local solicitation activity, does not align with concrete purchasing of this specific antiviral medication. The recent opportunities tagged under this code instead reflect acquisition of a broader range of pharmaceutical products, medical supplies, and pharmacy benefit services — including naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic multi-source pharmaceuticals and OTC products through cooperative purchasing, and direct-to-manufacturer prescription program capabilities. The issuing bodies span diverse state and local jurisdictions: Seminole County, Florida (health services procurement), the City of Tampa (fire department medical supplies), the Texas Health and Human Services Commission (pharmacy benefit program design), and the Minnesota Multistate Cooperative Purchasing Alliance serving state and local participants across multiple states including Oregon. This mix suggests the code captures pharmaceutical and medical product acquisition at county health departments, municipal emergency services, state health agencies, and multi-state cooperative purchasing vehicles rather than procurement specifically focused on antiretroviral therapies.

Activity appears concentrated in the Southeast and Midwest. The most recent concrete solicitation is IFB 60459723LAS from Seminole County, Florida (posted June 30, 2026, due July 26, 2023), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for community health initiatives. The City of Tampa issued IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies including respiratory equipment, cardiac monitoring electrodes, and oxygen delivery systems, estimated at $700,000, with a 5% bid discount for certified Small Local Business Enterprises. The Minnesota Multistate Cooperative Purchasing Alliance released RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, effective July 1, 2026. The Texas Health and Human Services Commission issued RFI HHS0017013 (posted April 3, 2026) to explore vendor capabilities for direct-to-manufacturer prescription programs. The code shows significant activity but limited evidence of elvitegravir-specific demand in recent state and local procurement.